Last Friday, Vancouver-headquartered Aurora announced it had purchased 450,000 common shares of CanniMed, equivalent to about 1.8 per cent of the company.
Aurora has said it’s allowed to buy up to about five per cent of the Saskatoon-headquartered CanniMed’s stock on the open market. This is its second purchase.
An acrimonious takeover battle between the two marijuana companies was in the regulatory spotlight earlier in December at a joint hearing involving the Saskatchewan and Ontario securities commissions.
Both companies have said they are pleased with a regulatory ruling dated Dec. 22 that gives each of them some of what they were seeking.
Any securities issued by CanniMed as a defence against a hostile takeover by Aurora will be cease-traded, the Ontario Securities Commission said. Aurora, for its part, will be required to amend its takeover bid circular and related press releases to include certain information that could affect CanniMed’s shareholders when they decide to accept or reject an offer.
- This is the Buds2Go Staff Account. We work really hard to provide information and news about marijuana legalization, product information and promotional events going on across Canada. We are fanatics and experts on strains and utilizing medical cannabis for the treatment of common ailments.
- News2018.10.19‘A 24/7 thing’: Ottawa police begin checkstop blitz to target cannabis-impaired drivers — even in the morning
- News2018.10.19Toronto police raid 5 marijuana dispensaries as retail locations still not permitted – Toronto
- News2018.10.19Former task force chair says everyone needs to obey the rules on legalized cannabis – New Brunswick
- News2018.10.16Halifax rolls out more designated smoking areas ahead of cannabis legalization – Halifax